scholarly journals Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours

2000 ◽  
Vol 53 (3) ◽  
pp. 129-132 ◽  
Author(s):  
I A Korneyev
Keyword(s):  
Transitional Cell ◽  
Nucleolar Organiser ◽  
Nucleolar Organiser Regions ◽  
Bladder Tumours

Prognostic Value of Flow Cytometry in Bladder Tumours

1993 ◽  
Vol 60 (2) ◽  
pp. 152-157
Author(s):  
D. Grassi ◽  
M. De Siati ◽  
N. Franzolin
Keyword(s):  
Flow Cytometry ◽  
Transitional Cell Carcinoma ◽  
Cell Carcinoma ◽  
Dna Content ◽  
Prognostic Value ◽  
Transitional Cell ◽  
Prognostic Information ◽  
Carcinoma Of The Bladder ◽  
Bladder Tumours

During this last decade, flow cytometry (FCM) has been widely investigated and employed in assessing the DNA content of bladder tumours. The prognostic value of FCM is recognised by the majority of investigators, above all when it concerns superficial transitional cell carcinoma of the bladder. The determination of ploidy and the degree of aneuploidy seem to offer valuable prognostic information. The Authors have reviewed Literature on this subject, identifying three different categories of studies that analyse the relation of FCM to cytohystological characterisation, to the clinical behaviour of the tumours and to the patients’ survival.

Value of counts on silver stained nucleolar organiser regions (AgNORs) in nasopharyngeal carcinoma (NFC)

Pathology ◽  
1990 ◽  
Vol 22 ◽  
pp. 2
Author(s):  
M. Arnold ◽  
A.C. Wallace ◽  
J.C.K. Lee ◽  
W.T. Leung ◽  
J.T. Li
Keyword(s):  
Nasopharyngeal Carcinoma ◽  
Nucleolar Organiser ◽  
Nucleolar Organiser Regions

Adjuvant Intravesical Chemotherapy in Patients with Primary T1 G3 Transitional Cell Carcinoma of the Bladder

1993 ◽  
Vol 60 (4) ◽  
pp. 345-348
Author(s):  
V. Serretta ◽  
S. Piazza ◽  
C. Pavone ◽  
G. Corselli ◽  
B. Piazza ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Transitional Cell Carcinoma ◽  
Carcinoma In Situ ◽  
Transitional Cell ◽  
Invasive Disease ◽  
Intravesical Chemotherapy ◽  
Carcinoma Of The Bladder ◽  
Bladder Tumours

The Authors present their experience with TUR plus adjuvant intravesical chemotherapy in 50 patients affected by primary T1 G3 bladder tumours without previous or concomitant carcinoma in situ. At a mean follow-up of 36 months, 84% of the patients are alive and tumour-free. Cystectomy was performed in three patients due to locally invasive disease. Five patients (10%) died of bladder cancer.

Sign in / Sign up

Export Citation Format

Share Document